A detailed history of State Of New Jersey Common Pension Fund D transactions in Axonics, Inc. stock. As of the latest transaction made, State Of New Jersey Common Pension Fund D holds 28,852 shares of AXNX stock, worth $2.05 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
28,852
Previous 27,473 5.02%
Holding current value
$2.05 Million
Previous $1.85 Million 8.83%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$67.3 - $69.67 $92,806 - $96,074
1,379 Added 5.02%
28,852 $2.01 Million
Q2 2024

Aug 07, 2024

SELL
$66.47 - $69.65 $874,213 - $916,036
-13,152 Reduced 32.37%
27,473 $1.85 Million
Q1 2024

May 02, 2024

SELL
$56.67 - $69.36 $136,348 - $166,880
-2,406 Reduced 5.59%
40,625 $2.8 Million
Q3 2023

Nov 08, 2023

SELL
$48.64 - $62.51 $315,187 - $405,064
-6,480 Reduced 13.09%
43,031 $2.41 Million
Q2 2023

Aug 02, 2023

BUY
$47.99 - $60.21 $418,760 - $525,392
8,726 Added 21.4%
49,511 $2.5 Million
Q1 2023

Apr 26, 2023

BUY
$52.6 - $67.34 $259,160 - $331,784
4,927 Added 13.74%
40,785 $2.23 Million
Q4 2022

Feb 01, 2023

BUY
$59.56 - $76.6 $167,244 - $215,092
2,808 Added 8.5%
35,858 $2.24 Million
Q3 2022

Oct 28, 2022

SELL
$57.96 - $78.12 $720,964 - $971,734
-12,439 Reduced 27.35%
33,050 $2.33 Million
Q2 2022

Aug 04, 2022

SELL
$39.5 - $64.42 $280,252 - $457,059
-7,095 Reduced 13.49%
45,489 $2.58 Million
Q1 2022

May 03, 2022

BUY
$43.74 - $62.76 $256,272 - $367,710
5,859 Added 12.54%
52,584 $3.29 Million
Q4 2021

Jan 31, 2022

BUY
$50.01 - $73.35 $502,650 - $737,240
10,051 Added 27.41%
46,725 $2.62 Million
Q3 2021

Oct 27, 2021

BUY
$59.21 - $78.66 $2.17 Million - $2.88 Million
36,674 New
36,674 $2.39 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track State Of New Jersey Common Pension Fund D Portfolio

Follow State Of New Jersey Common Pension Fund D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.